The group has its focus on the mechanisms of cellular invasion and on novel means of cancer treatment, developed through the targeting of cellular components involved in cancer invasion. In particular, we study the processes of extracellular matrix degradation through proteolytic and endocytic mechanisms and the utilization of the responsible molecular components for targeted drug delivery.